The UCLA CFAR Virology Core Laboratory has provided HIV-related tissue culture and molecular biology support for UCLA researchers since 1991. The Core has served as a resource for studies of HIV pathogenesis and the associated immune dysfunction. Specifically, the Core acts as a focal point for development and application of novel technologies in HIV molecular virologic assessment and as a bridge between basic and clinical studies conducted at UCLA. The Core also provides training to new investigators in HIV biosafety procedures. The overall purpose of the Core is to provide state of the art techniques of molecular virologic assessment as well as traditional cell culture methods to UCLA researchers. By making the assays and facilities of the Virology Core Facility available to all investigators at UCLA who are studying any aspect of HIV infection, we have successfully fostered interactions between scientists in several departments at the UCLA School of Medicine as well as the Schools of Public Health and Dentistry. Specifically, we will: 1. Maintain storage facilities and serum repositories for UCLA investigators. 2. Provide a biosafety level 3 facility for UCLA investigators. 3. Provide training in the procedures required for biosafety level facilities for UCLA investigators. 4. Introduce novel assays for use by UCLA investigators. 5. Promote the use of our assays and facilities by clinical, basic, public health and behavioral investigators.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI028697-12
Application #
6467985
Study Section
Project Start
2001-07-01
Project End
2002-06-30
Budget Start
Budget End
Support Year
12
Fiscal Year
2001
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Fulcher, Jennifer A; Shoptaw, Steven; Makgoeng, Solomon B et al. (2018) Brief Report: Recent Methamphetamine Use Is Associated With Increased Rectal Mucosal Inflammatory Cytokines, Regardless of HIV-1 Serostatus. J Acquir Immune Defic Syndr 78:119-123
Walser, Tonya C; Jing, Zhe; Tran, Linh M et al. (2018) Silencing the Snail-Dependent RNA Splice Regulator ESRP1 Drives Malignant Transformation of Human Pulmonary Epithelial Cells. Cancer Res 78:1986-1999
Kojima, Noah; Klausner, Jeffrey D (2018) Improving management of sexually transmitted infections in those who use pre-exposure prophylaxis for human immunodeficiency virus infection. AIDS 32:272-275
Chua, Bernadette Anne; Ngo, Jamie Ann; Situ, Kathy et al. (2018) Protein S and Gas6 induce efferocytosis of HIV-1-infected cells. Virology 515:176-190
Allyn, P R; O'Malley, S M; Ferguson, J et al. (2018) Attitudes and potential barriers towards hepatitis C treatment in patients with and without HIV coinfection. Int J STD AIDS 29:334-340
Khamaikawin, Wannisa; Shimizu, Saki; Kamata, Masakazu et al. (2018) Modeling Anti-HIV-1 HSPC-Based Gene Therapy in Humanized Mice Previously Infected with HIV-1. Mol Ther Methods Clin Dev 9:23-32
Foo, Suan-Sin; Chen, Weiqiang; Chan, Yen et al. (2018) Biomarkers and immunoprofiles associated with fetal abnormalities of ZIKV-positive pregnancies. JCI Insight 3:
Gorbach, Pamina M; Javanbakht, Marjan; Bolan, Robert K (2018) Behavior change following HIV diagnosis: findings from a Cohort of Los Angeles MSM. AIDS Care 30:300-304
Rotheram-Borus, Mary Jane; Davis, Emily; Rezai, Roxana (2018) Stopping the rise of HIV among adolescents globally. Curr Opin Pediatr 30:131-136
Allan-Blitz, Lao-Tzu; Sakona, Ashyln; Wallace, William D et al. (2018) Coxiella burnetii Endocarditis and Meningitis, California, USA, 2017. Emerg Infect Dis 24:

Showing the most recent 10 out of 942 publications